Robert Boisjoli FCPA, FCA, CBV, is a founder of AKESOgen and has served as Chief Executive Officer since the inception of the company.
Mr. Boisjoli is also a partner at Atwater Financial Group since 2003, a merchant-bank investor that provides a combination of investment banking and consultancy services. From 2008 to early 2010, he was Chief Financial Officer of Topigen Pharmaceutical Inc. until its sale in February 2010 to Pharmaxis, an Australian based biopharmaceutical company. From 2001 until 2008, Mr. Boisjoli was the Chief Financial Officer, Chief Operating Officer and co-founder of Xanthus Pharmaceuticals, Inc. until its sale in June 2008 to Antisoma PLC, a UK based biopharmaceutical company.
Mr. Boisjoli is a Fellow Professional Chartered Accountant (FCPA, CPA) and a Chartered Business Valuator (CBV) having obtained a Bachelor of Commerce and Diploma in Accounting at Concordia University.
Current role